Epidiolex, also known as purified cannabidiol was approved to treat Lennox-Gastaut syndrome and Dravet syndrome specifically in patients aged 2 and older. Both these conditions start during childhood. Recurrent seizures pose a huge risk of death.
The issue gained widespread public attention following the application by a boy’s family suffering from a rare form of epilepsy to use cannabis oil medication. The Home Secretary stated that a license would be issued for the boy’s treatment procedure to go ahead.
your submission has already been received.
Please enter a valid Email address！
The most relevant industry news & insight will be sent to you every two weeks.